BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20109045)

  • 1. Current management of pediatric acute otitis media.
    Leibovitz E; Broides A; Greenberg D; Newman N
    Expert Rev Anti Infect Ther; 2010 Feb; 8(2):151-61. PubMed ID: 20109045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management.
    Leibovitz E
    Paediatr Drugs; 2003; 5 Suppl 1():1-12. PubMed ID: 14632101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels.
    Couloigner V; Levy C; François M; Bidet P; Hausdorff WP; Pascal T; Boucherat M; Bingen E; Mariani P; Pierrot S; Bille E; Carbonnelle E; Varon E; Cohen R
    Pediatr Infect Dis J; 2012 Feb; 31(2):154-8. PubMed ID: 21983212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral beta-lactams in the treatment of acute otitis media.
    Block SL; Doern GV; Pfaller MA
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):19S-30S. PubMed ID: 17349460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute otitis media caused by Streptococcus pyogenes in children.
    Segal N; Givon-Lavi N; Leibovitz E; Yagupsky P; Leiberman A; Dagan R
    Clin Infect Dis; 2005 Jul; 41(1):35-41. PubMed ID: 15937760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines.
    Segal N; Leibovitz E; Dagan R; Leiberman A
    Int J Pediatr Otorhinolaryngol; 2005 Oct; 69(10):1311-9. PubMed ID: 15955573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
    Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
    Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute otitis media in children aged less than 2 years: drug treatment issues.
    Leibovitz E
    Paediatr Drugs; 2006; 8(6):337-46. PubMed ID: 17154641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections.
    Klein JO
    Am J Manag Care; 2002 Oct; 8(14 Suppl):S345-52. PubMed ID: 12408220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?
    Leibovitz E; Satran R; Piglansky L; Raiz S; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 Jun; 22(6):509-15. PubMed ID: 12799507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otitis media. A scholarly review of the evidence.
    Pappas DE; Owen Hendley J
    Minerva Pediatr; 2003 Oct; 55(5):407-14. PubMed ID: 14608264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Past, present, and future: an overview of the microbiology of acute otitis media.
    Harrison CJ
    Postgrad Med; 2005 Dec; 118(6 Suppl Emerging):32-3, 13-23. PubMed ID: 19667701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in otitis media.
    Pelton SI; Leibovitz E
    Pediatr Infect Dis J; 2009 Oct; 28(10 Suppl):S133-7. PubMed ID: 19918136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the presence of drug-resistant bacteria and recurrent acute otitis media in children--a study in a private clinic.
    Kikuta S; Ushio M; Fujimaki Y; Kaga K
    Acta Otolaryngol Suppl; 2007 Dec; (559):5-8. PubMed ID: 18340553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
    Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complicated otitis media and its implications.
    Leibovitz E
    Vaccine; 2008 Dec; 26 Suppl 7():G16-9. PubMed ID: 19094932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute otitis media caused by drug-resistant bacteria: correlation with antibiotic treatment.
    Sakakura K; Chikamatsu K; Furukawa M; Shibasaki M; Takegoshi T; Takahashi K; Furuya N
    Acta Otolaryngol; 2004 Nov; 124(9):1008-14. PubMed ID: 15513542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine.
    Brunton S
    Clin Ther; 2006 Jan; 28(1):118-23. PubMed ID: 16490585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.